Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Severity of the Omicron SARS‐CoV‐2 variant compared with the previous lineages: A systematic review
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 33
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 25
Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks
Mohammed Albreiki, Mira Mousa, Syafiq Kamarul Azman, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study
Jingxing Li, Pei‐Lun Liao, James Cheng‐Chung Wei, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
Bezawit A. Woldemeskel, Caroline C. Garliss, Tihitina Y. Aytenfisu, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 20
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program
M. Daniel Brannock, Robert F. Chew, Alexander Preiss, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 18
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021
Tom Woudenberg, Laurie Pinaud, Laura García, et al.
Eurosurveillance (2023) Vol. 28, Iss. 25
Open Access | Times Cited: 11
COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022
Piotr Rzymski, Nadiia Kasianchuk, Dominika Sikora, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 15
Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
Amr Kandeel, Yassmin Moatasim, Manal Fahim, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design
Yansheng Liu, Zhenle Qin, Jin Zhou, et al.
RSC Advances (2023) Vol. 13, Iss. 26, pp. 17883-17906
Open Access | Times Cited: 6
A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial
Yu Cao, Xiaoli Wang, Siqi Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 8, pp. 1677-1679
Open Access | Times Cited: 10
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Effectiveness of Covid-19 vaccines against SARS-CoV-2 Omicron variant (B.1.1.529): A systematic review with meta-analysis and meta-regression
Nando Reza Pratama, Ifan Ali Wafa, David Setyo Budi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Understanding risk factors of a new variant outburst through global analysis of Omicron transmissibility
Marko Djordjević, Sofija Marković, Igor Salom, et al.
Environmental Research (2022) Vol. 216, pp. 114446-114446
Closed Access | Times Cited: 5
An interactive agent-based modelling framework for assessing COVID-19 transmission risk on construction site
Qingyao Qiao, Clara Cheung, Akilu Yunusa‐Kaltungo, et al.
Safety Science (2023) Vol. 168, pp. 106312-106312
Open Access | Times Cited: 2
Characterization of antibody and T-cell response after second booster vaccination
Katharina Grikscheit, Holger F. Rabenau, Zahra Ghodatrian, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Real-world data concerning the efficacy of molnupiravir in patients vaccinated against COVID-19 during the Omicron surge in Japan
Satoshi Inaba, Naoya Nishioka, Hisatoshi Okumura, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Projecting the impact of the introduction of SARS-CoV-2 Omicron variant in China in the context of waning immunity after vaccination
Hongjie Yu, Jun Cai, Xiaowei Deng, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Returning persons with SARS-CoV-2 to the field of play in professional golf: a risk assessment and risk reduction approach
Patrick G. Robinson, Andrew Murray, Graeme L. Close, et al.
BMJ Open Sport & Exercise Medicine (2022) Vol. 8, Iss. 2, pp. e001347-e001347
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top